SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 8th, 2023 • Transcode Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 8th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 6, 2023, between TransCode Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).